Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

COVID-19 Spurred Rapid Growth for iGaming Industry, Playgon Games Inc. (TSX.V: DEAL) (OTCQB: PLGNF) Positioned Favorably with Privacy-Focused Software

Research and Markets released new online gaming industry report, expecting significant growth with CAGR of 11.94% between 2021-2026 Swedish University study suggests rapid growth in online gaming resulted from COVID-19 lockdowns Grand View Research report predicts online gambling market will reach $127.3 billion by 2027 PLGNF provides multi-tenant gateway that enables online operators to offer […]

FingerMotion Inc. (FNGR) Poised to Surf Potential Wave of 5G Growth in China Through Partnerships, Mobile Services

U.S.-based mobile tech services provider FingerMotion is laser-focused on the Chinese phone consumer market, building revenues primarily from SMS and MMS services there but expanding into insurance data services with other corporate partners The company’s trademarked big data platform Sapientus handles over half a million transactions daily for its mobile payment and recharge services Analysts […]

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Moves ‘One Step Closer’ to Creating Best Therapy for Mental Health

Company releases positive results from preclinical study focusing on psilocybin program CYB003 Multiple academic studies have shown that psilocybin may have the potential to revolutionize mental healthcare Results indicate less patient variability, faster onset of action, shorter duration of effect and improved brain penetration According to the National Institute of Mental Health, some 17.3 million […]

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Expands its Product Line with Acquisition of Majority Equity Interests in Eh Coffee Corp. and Portfolio Coffee Inc.

PlantX just acquitted a 53.5% stake at Eh Coffee and a 51% stake at Portfolio Coffee Inc. The acquisition marks PlantX’s addition of coffee to its line of over 5,000 plant-based products PlantX will push products from these two companies on its e-commerce platform and physical XMarket stores PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: […]

Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces 2022 DehydraTECH(TM) R&D Programs, Including Investigations into Alzheimer’s Disease and Diabetes

Lexaria’s 2022 R&D programs are set to include research on hormone replacement, dementia, rheumatoid disease, and diabetes, among other conditions The program builds on findings from 2021 studies which supported significant advances in the oral nicotine, heart disease, and antiviral markets The 2022 program will continue to focus on the company’s patented DehydraTECH drug delivery […]

Nemaura Medical Inc. (NASDAQ: NMRD) Offers ‘First-of-a-Kind’ Device in Growing CGM Market

The global continuous glucose monitoring devices market size is expected to reach $19.04 billion in 2028 The increasing prevalence of diabetes, rising focus on preventive care are significant factors in the steady revenue growth Nemaura Medical’s sugarBEAT device allows individuals to make adjustments to diet and activity that can significantly change their lives According to a recent […]

Hero Technologies Inc. (HENC) Subsidiary Looks to Leverage Position in $2B Massachusetts Marijuana Market

HENC subsidiary evaluating, pursuing property acquisitions; beginning process to obtain cultivation, sales licenses Sales have doubled in the past year, according to state’s seed-to-sale tracking system HENC working with top cannabis law firm to spearhead the process With Massachusetts reporting marijuana sales reaching $2 billion since the state approved the adult-use market (https://ibn.fm/S8IvV), savvy cannabis […]

SRAX Inc. (NASDAQ: SRAX) Set to Publish Third Quarter 2021 Results on Monday 15th November; Simultaneously Reveal Upcoming Attendance at the Ladenburg Thalmann Virtual Technology Expo

SRAX will publish its third quarter quarterly results on Monday 15th November The company will also hold an investor earnings call alongside the results release, led by SRAX CEO, Christopher Miglino and CFO, Michael Malone Following their second quarter results, the company upped its 3Q revenue guidance to $8.3 million, representing a +7.7% quarter-on-quarter crisis […]

Marijuana Company of America Inc. (MCOA) Is ‘One to Watch’

The VBF acquisition is expected to be accretive to MCOA’s revenue and EBITDA forecasts for 2022 The company launched new subsidiaries in Brazil and Uruguay to distribute its hempsmart premium product line in Latin America The company recently launched a new social media marketing campaign via Instagram, Twitter, TikTok, etc. The global legal marijuana market […]

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Playing Foremost Role in Eliminating Barriers of Entry to Plant-Based Lifestyle through Education, Ever-Expanding Marketplace

PlantX Life is the digital face of the plant-based community that offers over 5,000 products through its ever-expanding marketplace The company is also committed to educating and empowering people interested in the plant-based lifestyle PlantX regularly updates its website with blogs and articles about living a holistic      plant-based lifestyle Through its YouTube channel, […]

 

From Our Blog

HeartBeam Inc. (NASDAQ: BEAT) Advances Remote Cardiac Diagnostics with HeartNexus Partnership

November 13, 2025

HeartBeam (NASDAQ: BEAT), a medical-technology company developing next-generation cardiac diagnostics via its patented 12-Lead ECG synthesis software, has announced a strategic collaboration with HeartNexus (https://ibn.fm/yyz1i). The partnership will expand access to cardiologist-level ECG insights for arrhythmia assessment anytime, anywhere. Cardiovascular disease remains the leading cause of mortality worldwide, responsible for an estimated 17.9 million deaths […]

Rotate your device 90° to view site.